(Q44487970)

3 December 2017

title

Sputum cytokine mapping reveals an 'IL-5, IL-17A, IL-25-high' pattern associated with poorly controlled asthma (English)

1 reference

3 December 2017

0 references

0 references

Jeroen Alfons Vanoirbeek

6

1 reference

3 December 2017

W Adriaensen

3

0 references

author name string

S F Seys

1

1 reference

3 December 2017

M Grabowski

2

1 reference

3 December 2017

A Decraene

4

1 reference

3 December 2017

E Dilissen

5

1 reference

3 December 2017

L J Dupont

7

1 reference

3 December 2017

J L Ceuppens

8

1 reference

3 December 2017

D M A Bullens

9

1 reference

3 December 2017

publication date

1 September 2013

1 reference

Clinical & Experimental Allergy

3 December 2017

published in

1 reference

3 December 2017

volume

43

1 reference

3 December 2017

issue

9

1 reference

3 December 2017

page(s)

1009-1017

1 reference

3 December 2017

1 reference

Asthma: defining of the persistent adult phenotypes

21 January 2018

1 reference

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

21 January 2018

1 reference

T-helper type 2-driven inflammation defines major subphenotypes of asthma.

21 January 2018

1 reference

Importance of cytokines in murine allergic airway disease and human asthma

21 January 2018

1 reference

The role of T lymphocytes in asthma

21 January 2018

1 reference

Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients.

21 January 2018

1 reference

Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma

21 January 2018

1 reference

Interferon-gamma as a possible target in chronic asthma

21 January 2018

1 reference

Differences in airway cytokine profile in severe asthma compared to moderate asthma.

21 January 2018

1 reference

The cytokine network in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

IL-17-producing T cells in lung immunity and inflammation

21 January 2018

1 reference

Neutrophils, interleukin-17A and lung disease

21 January 2018

1 reference

IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?

21 January 2018

1 reference

Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes

21 January 2018

1 reference

Evidence of a role of tumor necrosis factor alpha in refractory asthma

21 January 2018

1 reference

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma

21 January 2018

1 reference

IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells

21 January 2018

1 reference

Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses

21 January 2018

1 reference

Choice of Mouse Strain Influences the Outcome in a Mouse Model of Chemical-Induced Asthma

21 January 2018

1 reference

Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells

21 January 2018

1 reference

Innate immune cell populations function as initiators and effectors in Th2 cytokine responses

21 January 2018

1 reference

A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma

21 January 2018

1 reference

Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells.

21 January 2018

1 reference

Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3.

21 January 2018

1 reference

Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology

21 January 2018

1 reference

Mepolizumab and exacerbations of refractory eosinophilic asthma

21 January 2018

1 reference

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEA.12125

1 reference

3 December 2017

1 reference